Collegium Pharmaceutical, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of COLL for the last quarter is 149.75 M USD, and it's 9.54% higher compared to the previous quarter. The net income of Q4 23 is 31.94 M USD.